Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms

摘要

The present invention relates to new compounds of Formula (I): and pharmaceutically acceptable forms thereof, use of the compounds as alpha_1a and/or alpha_1d adrenoreceptor modulators, including use of a pharmaceutical composition, medicine or medicament comprising said compounds, a process to prepare said compounds and a method for treating an alpha_1a and/or alpha_1d adrenoreceptor mediated disorder.